UNIVERSITY HEALTH NETWORK

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 64191
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 40200
 
  
 
C07D HETEROCYCLIC COMPOUNDS 27135
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 25181
 
  
 
C07K PEPTIDES 22114
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 21146
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13112
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1097
 
  
 
G06K RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 8190
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 7440

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0015,066 DRUG COMPLEXES COMPRISING ALPHA-FETOPROTEINJan 26, 16Jan 18, 18[A61K, C07D, C07K]
2018/0016,320 METHODS AND COMPOSITIONS FOR MODULATING TOSO ACTIVITYMay 01, 17Jan 18, 18[A61K, C07K]
2017/0319,719 J-Aggregate Forming NanoparticleJul 27, 17Nov 09, 17[A61K]
2017/0315,119 URINARY BIOMARKERS FOR SLE AND LUPUS NEPHRITISOct 07, 15Nov 02, 17[G01N]
2017/0128,591 Peptide Containing Porphyrin Lipid NanovesiclesJun 18, 15May 11, 17[A61K, B82Y]
2017/0089,929 Antibodies to TTR and Methods of UseDec 09, 16Mar 30, 17[G01N, C07K]
2017/0015,737 ANTI-TRANSTHYRETIN ANTIBODIESJul 02, 16Jan 19, 17[A61K, G01N, C07K]
2016/0361,391 REDUCTION OF TRAF1 LEVELS COMBINED WITH NUTRIENT STRESS FOR TREATING LYMPHOCYTE-RELATED CANCERSMar 06, 15Dec 15, 16[A61K, C12N, G01N]
2016/0340,403 METHODS AND COMPOSITIONS FOR PRODUCING A CELL EXPRESSING A T CELL RECEPTORJan 28, 15Nov 24, 16[C12N, C07K]
2016/0333,421 Biopsy-Driven Genomic Signature for Prostate Cancer PrognosisJan 16, 15Nov 17, 16[C12Q, G06F]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9907800 Kinase inhibitors and method of treating cancerAug 11, 15Mar 06, 18[A61K, C07D]
9908853 Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereofAug 01, 13Mar 06, 18[C07D]
9884855 Salt and crystal forms of PLK-4 inhibitorOct 17, 14Feb 06, 18[A61K, C07D]
9879080 Anti-transthyretin antibodiesJul 02, 16Jan 30, 18[A61K, G01N, C07K]
9857443 Method and apparatus for the measurement, characterization and correction of geometric distortions in magnetic resonance imagingMar 14, 14Jan 02, 18[G01R, G01V]
9833446 Hedgehog pathway inhibition for cartilage tumor and metachondromatosis treatmentMar 14, 13Dec 05, 17[A61K]
9834754 Populations of hematopoietic progenitors and methods of enriching stem cells thereforNov 21, 12Dec 05, 17[C12N, G01N]
9835630 Methods and compositions for assessing lung graftsFeb 20, 14Dec 05, 17[G01N, C40B]
9836950 Hand hygiene complianceAug 12, 14Dec 05, 17[G08B, G07C]
9801590 Breathing disorder identification, characterization and diagnosis methods, devices and systemsMay 17, 12Oct 31, 17[A61B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0029,515 METHOD OF INHIBITION OF LEUKEMIC STEM CELLSAbandonedAug 10, 16Feb 02, 17[A61K, C07K]
2016/0257,736 ANTI-TRANSTHYRETIN ANTIBODIESAbandonedJan 28, 16Sep 08, 16[C07K]
2016/0257,737 ANTI-TRANSTHYRETIN ANTIBODIESAbandonedJan 28, 16Sep 08, 16[C07K]
2016/0251,418 ANTI-TRANSTHYRETIN ANTIBODIESAbandonedJan 28, 16Sep 01, 16[C07K]
2016/0250,309 COMPOSITIONS AND METHODS FOR CANCER TREATMENTAbandonedJan 26, 16Sep 01, 16[A61K, C12N, C07K]
2016/0074,533 VECTOR ENCODING THERAPEUTIC POLYPEPTIDE AND SAFETY ELEMENTS TO CLEAR TRANSDUCED CELLSAbandonedNov 23, 15Mar 17, 16[A61K, C12N]
2015/0376,723 PROGNOSTIC BIOMARKERS FOR INFLUENZAAbandonedJun 29, 15Dec 31, 15[C12Q]
2015/0359,912 J-Aggregate Forming NanoparticleAbandonedJan 28, 14Dec 17, 15[A61K]
2015/0241,429 IRHOM2 INHIBITION FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERSAbandonedSep 11, 13Aug 27, 15[C12Q, G01N]
2015/0152,185 METHOD OF INHIBITION OF LEUKEMIC STEM CELLSAbandonedNov 25, 14Jun 04, 15[A61K, C07K]
2015/0104,815 Porphyrin-Lipid Stabilized Nanoparticles for Surface Enhanced Raman Scattering Based ImagingAbandonedApr 19, 13Apr 16, 15[G01N]
2015/0072,349 Cancer Biomarkers and Methods of UseAbandonedMar 15, 13Mar 12, 15[G01N]
2014/0370,039 IL-12 IMMUNOTHERAPY FOR CANCERAbandonedMay 21, 14Dec 18, 14[A61K, C07K]
2014/0363,900 Giant Porphyrin-Phospholipid VesiclesAbandonedDec 05, 12Dec 11, 14[C12Q, G01N]
2014/0306,495 PATIENT CARRIERAbandonedApr 10, 14Oct 16, 14[A61G]
2014/0257,100 Porphyrin MicrobubblesAbandonedOct 11, 12Sep 11, 14[A61K, A61B]
2014/0242,095 ANTIBODIES AND ANTIBODY FRAGMENTS TARGETING SIRP-ALPHA AND THEIR USE IN TREATING HEMATOLOGIC CANCERSAbandonedOct 19, 12Aug 28, 14[C07K]
2014/0221,301 COMBINATION TREATMENT FOR CANCERAbandonedJul 13, 12Aug 07, 14[A61K, C12Q]
2014/0221,619 Methods and Compositions for Increasing Protein ProductionAbandonedFeb 26, 14Aug 07, 14[C07K]
2014/0193,449 COMPOSITIONS AND METHODS FOR CANCER TREATMENTAbandonedJan 08, 14Jul 10, 14[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.